Investor Presentaiton

Solid 8% organic growth in Q2 with broad-based contribution from all business areas and regions excluding China Q2 2022/23 revenue by business area Q2 2022/23 revenue by geography 5 Business area Ostomy Care Continence Care Reported revenue FY DKKm Organic growth Share of organic Geographic FY growth area 2,204 6% 28% European markets 6% 26% 1,964 Reported revenue FY DKKm FY Organic growth Share of organic growth 3,444 6% 43% Voice & 9% 6% Respiratory Care* 479 Other developed markets 1,553 13% 38% Wound & Skin 747 13% 19% Care Emerging markets 1,064 9% 19% Interventional 667 17% 21% Urology Coloplast Group *Part of organic growth since February 1, 2023 6,061 8% 100% Coloplast Group 6,061 8% 100% Coloplast

View entire presentation